Evidence-Based Complementary and Alternative Medicine / 2018 / Article / Tab 4

Research Article

An Herbal Medicine, Yukgunja-Tang is more Effective in a Type of Functional Dyspepsia Categorized by Facial Shape Diagnosis: A Placebo-Controlled, Double-Blind, Randomized Trial

Table 4

Change rate of TDS scale, SDS scale, VAS for overall dyspeptic symptoms, NDI-K, FD-QoL questionnaire, SQDQ, and proportion of responders.

Change rate of variables/GroupGallbladder bodyBladder bodyPlaceboP value
(n = 32)(n = 32)(n = 32)

TDS scale0.53 (0.38)0.61 (0.31)0.32 (0.54)0.038
SDS scale0.55 (0.36)0.57 (0.43)0.34 (0.72)0.163
VAS for overall dyspeptic symptoms0.43 (0.25)0.48 (0.38)0.41 (0.28)0.692
NDI-K0.57 (0.35)0.61 (0.42)0.44 (0.49)0.274
FD-QoL questionnaire0.58 (0.40)0.64 (0.31)0.19 (2.20)0.338
SQDQ0.36 (0.35)0.44 (0.33)0.34 (0.36)0.457
Proportion of responders (%)

TDS: Total Dyspepsia Symptom; SDS: Single Dyspepsia Symptom; VAS: Visual Analogue Scale; NDI-K: Nepean Dyspepsia Index-Korean Version; FD-QoL: Functional Dyspepsia-Related Quality of Life; SQDQ: Spleen Qi Deficiency Questionnaire.
Both gallbladder and bladder body groups are treatment groups.
Change rate is defined as the value obtained by subtracting the value of 8 weeks from the value of baseline and dividing it by the value of baseline.
Values were analyzed by Pearson's chi-squared test for categorical variables and one way-ANOVA for continuous variables.
Continuous variables are presented as mean (standard deviation).
P value < 0.05 is regarded as statistically significant.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.